Cabozantinib Plus Telgaglenstat (CB-839): A Phase II Combination in Patients with Well-Differentiated Gastroenteropancreatic NETs

Cabozantinib Plus Telgaglenstat (CB-839): A Phase II Combination in Patients with Well-Differentiated Gastroenteropancreatic NETs

Das

Download The Abstract

Download The Poster